1887

Abstract

The ability to induce several cytokines relevant to tuberculosis (TNF-α, IL-1β, IL-6, IL-12p40 and IL-23) by cord factor (trehalose dimycolate) from CR-21 and CR-270 was studied in the cell lines RAW 264.7 and THP-1, and compared to the ability of cord factor from H37Rv, where this glycolipid appears to be implicated in the pathogenesis of tuberculosis. Details of the fine structure of these molecules were obtained by NMR and MS. The mycoloyl residues were identified as α and (ω-1)-methoxy in CR-21 and α in CR-270; in both cases they were di-unsaturated instead of cyclopropanated as found in . In RAW 264.7 cells, cord factors from CR-21, CR-270 and differed in their ability to stimulate IL-6, the higher levels corresponding to the cord factor from . In THP-1 cells, a similar overall profile of cytokines was found for CR-21 and CR-270, with high proportions of IL-1β and TNF-α, and different from , where IL-6 and IL-12p40 prevailed. The data obtained indicate that cord factors from the atypical mycobacteria CR-21 and CR-270 stimulated the secretion of several pro-inflammatory cytokines, although there were some differences with those of H37Rv. This finding seems to be due to their particular mycoloyl substituents and could be of interest when considering the potential adjuvanticity of these molecules.

Funding
This study was supported by the:
  • Ministerio de Ciencia e Innovación, Spain
  • European Union, FEDER (Award PI080079)
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.060681-0
2012-11-01
2024-10-09
Loading full text...

Full text loading...

/deliver/fulltext/micro/158/11/2878.html?itemId=/content/journal/micro/10.1099/mic.0.060681-0&mimeType=html&fmt=ahah

References

  1. Ausina V., Luquin M., García Barceló M., Lanéelle M. A., Lévy-Frébault V., Belda F., Prats G. ( 1992). Mycobacterium alvei sp. nov.. Int J Syst Bacteriol 42:529–535 [View Article] [PubMed]
    [Google Scholar]
  2. Beckman E. M., Porcelli S. A., Morita C. T., Behar S. M., Furlong S. T., Brenner M. B. ( 1994). Recognition of a lipid antigen by CD1-restricted α β+ T cells. Nature 372:691–694 [View Article] [PubMed]
    [Google Scholar]
  3. Bloch H. ( 1950). Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms. J Exp Med 91:197–218 [View Article] [PubMed]
    [Google Scholar]
  4. Bowdish D. M. E., Sakamoto K., Kim M.-J., Kroos M., Mukhopadhyay S., Leifer C. A., Tryggvason K., Gordon S., Russell D. G. ( 2009). MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis . PLoS Pathog 5:e1000474 [View Article] [PubMed]
    [Google Scholar]
  5. Brennan P. J., Nikaido H. ( 1995). The envelope of mycobacteria. Annu Rev Biochem 64:29–63 [View Article] [PubMed]
    [Google Scholar]
  6. Cooper A. M., Khader S. A. ( 2008). The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226:191–204 [View Article] [PubMed]
    [Google Scholar]
  7. Cruz A., Fraga A. G., Fountain J. J., Rangel-Moreno J., Torrado E., Saraiva M., Pereira D. R., Randall T. D., Pedrosa J. & other authors ( 2010). Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis . J Exp Med 207:1609–1616 [View Article] [PubMed]
    [Google Scholar]
  8. Daffé M., Draper P. ( 1997). The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39:131–203 [View Article] [PubMed]
    [Google Scholar]
  9. Dao D. N., Sweeney K., Hsu T., Gurcha S. S., Nascimento I. P., Roshevsky D., Besra G. S., Chan J., Porcelli S. A., Jacobs W. R. Jr ( 2008). Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4:e1000081 [View Article] [PubMed]
    [Google Scholar]
  10. Dobson G., Minnikin D. E., Minnikin S. M., Parlett J. H., Goodfellow M., Ridell M., Magnusson M. ( 1985). Systematic analysis of complex mycobacterial lipids. Chemical Methods in Bacterial Systematics237–265 Goodfellow M., Minnikin D. E. London: Academic Press;
    [Google Scholar]
  11. Eckstein T. M., Chandrasekaran S., Mahapatra S., McNeil M. R., Chatterjee D., Rithner C. D., Ryan P. W., Belisle J. T., Inamine J. M. ( 2006). A major cell wall lipopeptide of Mycobacterium avium subspecies paratuberculosis . J Biol Chem 281:5209–5215 [View Article] [PubMed]
    [Google Scholar]
  12. Falkinham J. O. III ( 1996). Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9:177–215 [PubMed]
    [Google Scholar]
  13. Fujita Y., Okamoto Y., Uenishi Y., Sunagawa M., Uchiyama T., Yano I. ( 2007). Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb Pathog 43:10–21 [View Article] [PubMed]
    [Google Scholar]
  14. Geisel R. E., Sakamoto K., Russell D. G., Rhoades E. R. ( 2005). In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates. J Immunol 174:5007–5015 [PubMed] [CrossRef]
    [Google Scholar]
  15. Hayashi D., Takii T., Fujiwara N., Fujita Y., Yano I., Yamamoto S., Kondo M., Yasuda E., Inagaki E. & other authors ( 2009). Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guérin (BCG) substrains. FEMS Immunol Med Microbiol 56:116–128 [View Article] [PubMed]
    [Google Scholar]
  16. Hunter R. L., Armitige L., Jagannath C., Actor J. K. ( 2009). TB research at UT-Houston–a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis. Tuberculosis (Edinb) 89:Suppl. 1S18–S25 [View Article] [PubMed]
    [Google Scholar]
  17. Indrigo J., Hunter R. L. Jr, Actor J. K. ( 2002). Influence of trehalose 6,6′-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 148:1991–1998 [PubMed]
    [Google Scholar]
  18. Indrigo J., Hunter R. L. Jr, Actor J. K. ( 2003). Cord factor trehalose 6,6′-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149:2049–2059 [View Article] [PubMed]
    [Google Scholar]
  19. Ishikawa E., Ishikawa T., Morita Y. S., Toyonaga K., Yamada H., Takeuchi O., Kinoshita T., Akira S., Yoshikai Y., Yamasaki S. ( 2009). Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206:2879–2888 [View Article] [PubMed]
    [Google Scholar]
  20. Karakousis P. C., Bishai W. R., Dorman S. E. ( 2004). Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol 6:105–116 [View Article] [PubMed]
    [Google Scholar]
  21. Khader S. A., Bell G. K., Pearl J. E., Fountain J. J., Rangel-Moreno J., Cilley G. E., Shen F., Eaton S. M., Gaffen S. L. & other authors ( 2007). IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8:369–377 [View Article] [PubMed]
    [Google Scholar]
  22. Kim M.-J., Wainwright H. C., Locketz M., Bekker L.-G., Walther G.-B., Dittrich C., Visser A., Wang W., Hsu F.-F. & other authors ( 2010). Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2:258–274 [View Article] [PubMed]
    [Google Scholar]
  23. Korbel D. S., Schneider B. E., Schaible U. E. ( 2008). Innate immunity in tuberculosis: myths and truth. Microbes Infect 10:995–1004 [View Article] [PubMed]
    [Google Scholar]
  24. Korf J., Stoltz A., Verschoor J., De Baetselier P., Grooten J. ( 2005). The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur J Immunol 35:890–900 [View Article] [PubMed]
    [Google Scholar]
  25. Lima V. M. F., Bonato V. L. D., Lima K. M., Dos Santos S. A., Dos Santos R. R., Gonçalves E. D. C., Faccioli L. H., Brandão I. T., Rodrigues-Junior J. M., Silva C. L. ( 2001). Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis. Infect Immun 69:5305–5312 [View Article] [PubMed]
    [Google Scholar]
  26. Lima K. M., Santos S. A., Lima V. M. F., Coelho-Castelo A. A., Rodrigues J. M. Jr, Silva C. L. ( 2003). Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis . Gene Ther 10:678–685 [View Article] [PubMed]
    [Google Scholar]
  27. Luquin M., Roussel J., López-Calahorra F., Lanéelle G., Ausina V., Lanéelle M. A. ( 1990). A novel mycolic acid in a Mycobacterium sp. from the environment. Eur J Biochem 192:753–759 [View Article] [PubMed]
    [Google Scholar]
  28. Luquin M., Ausina V., Vincent-Lévy-Frebault V., Lanéelle M. A., Belda F., García-Barceló M., Prats G., Daffé M. ( 1993). Mycobacterium brumae sp. nov., a rapidly growing, nonphotochromogenic mycobacterium. Int J Syst Bacteriol 43:405–413 [View Article]
    [Google Scholar]
  29. Mederos L. M., Montoro E. H., Bernabéu A., Linares C., Valero-Guillén P. L. ( 2010). Structural studies of cord factors from Mycobacterium simiae related to the capacity for tumour necrosis factor alpha (α-TNF) induction. Microbiology 156:3744–3753 [View Article] [PubMed]
    [Google Scholar]
  30. Méndez-Samperio P. ( 2010). Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease. Int J Infect Dis 14:e366–e371 [View Article] [PubMed]
    [Google Scholar]
  31. Minnikin D. E. ( 1982). Lipids: complex lipids. The Biology of the Mycobacteria vol. 195–184 Ratledge C., Stanford J. L. London: Academic Press;
    [Google Scholar]
  32. Montamat-Sicotte D. J., Millington K. A., Willcox C. R., Hingley-Wilson S., Hackforth S., Innes J., Kon O.-M., Lammas D. A., Minnikin D. E. & other authors ( 2011). A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest 121:2493–2503 [View Article] [PubMed]
    [Google Scholar]
  33. Noll H., Bloch H., Asselineau J., Lederer E. ( 1956). The chemical structure of the cord factor of Mycobacterium tuberculosis . Biochim Biophys Acta 20:299–309 [View Article] [PubMed]
    [Google Scholar]
  34. Peyron P., Vaubourgeix J., Poquet Y., Levillain F., Botanch C., Bardou F., Daffé M., Emile J.-F., Marchou B. & other authors ( 2008). Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4:e1000204 [PubMed] [CrossRef]
    [Google Scholar]
  35. Rao V., Fujiwara N., Porcelli S. A., Glickman M. S. ( 2005). Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201:535–543 [View Article] [PubMed]
    [Google Scholar]
  36. Rao V., Gao F., Chen B., Jacobs W. R. Jr, Glickman M. S. ( 2006). Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. J Clin Invest 116:1660–1667 [View Article] [PubMed]
    [Google Scholar]
  37. Rhoades E., Hsu F. F., Torrelles J. B., Turk J., Chatterjee D., Russell D. G. ( 2003). Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol Microbiol 48:875–888 [View Article] [PubMed]
    [Google Scholar]
  38. Russell D. G. ( 2007). Who puts the tubercle in tuberculosis?. Nat Rev Microbiol 5:39–47 [View Article] [PubMed]
    [Google Scholar]
  39. Schoenen H., Bodendorfer B., Hitchens K., Manzanero S., Werninghaus K., Nimmerjahn F., Agger E. M., Stenger S., Andersen P. & other authors ( 2010). Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 184:2756–2760 [View Article] [PubMed]
    [Google Scholar]
  40. Takayama K., Wang C., Besra G. S. ( 2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis . Clin Microbiol Rev 18:81–101 [View Article] [PubMed]
    [Google Scholar]
  41. Vander Beken S., Al Dulayymi J. R., Naessens T., Koza G., Maza-Iglesias M., Rowles R., Theunissen C., De Medts J., Lanckacker E. & other authors ( 2011). Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur J Immunol 41:450–460 [View Article] [PubMed]
    [Google Scholar]
  42. Watanabe M., Aoyagi Y., Ridell M., Minnikin D. E. ( 2001). Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147:1825–1837 [PubMed]
    [Google Scholar]
  43. Welsh K. J., Abbott A. N., Hwang S.-A., Indrigo J., Armitige L. Y., Blackburn M. R., Hunter R. L. Jr, Actor J. K. ( 2008). A role for tumour necrosis factor-α, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6′-dimycolate induced granulomatous response. Microbiology 154:1813–1824 [View Article] [PubMed]
    [Google Scholar]
  44. Werninghaus K., Babiak A., Gross O., Holscher C., Dietrich H., Agger E. M., Mages J., Mocsai A., Schoenen H. & other authors ( 2009). Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9-dependent innate immune activation. J Exp Med 206:89–97 [View Article]
    [Google Scholar]
  45. Zähringer U., Lindner B., Inamura S., Heine H., Alexander C. ( 2008). TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213:205–224 [View Article] [PubMed]
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.060681-0
Loading
/content/journal/micro/10.1099/mic.0.060681-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error